Cargando…

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study

INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Więckiewicz, Gniewko, Stokłosa, Iga, Stokłosa, Maciej, Więckiewicz, Włodzimierz, Gorczyca, Piotr, Gondek, Tomasz M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366592/ https://www.ncbi.nlm.nih.gov/pubmed/37496681 http://dx.doi.org/10.3389/fpsyt.2023.1184023

Ejemplares similares

Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
por: Wieckiewicz, Gniewko, et al.
Publicado: (2022)

The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey
por: Więckiewicz, Gniewko, et al.
Publicado: (2023)

Medications for the Treatment of Alcohol Dependence—Current State of Knowledge and Future Perspectives from a Public Health Perspective
por: Stokłosa, Iga, et al.
Publicado: (2023)

Analysis of High-Risk Sexual Behavior among Polish University Students
por: Stokłosa, Iga, et al.
Publicado: (2021)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

Mercy Procedure or a Nightmare? Attitude towards Pregnancy Termination among Polish University Students
por: Stokłosa, Maciej, et al.
Publicado: (2021)

Influence of Selected Sociodemographic and Cultural Factors on the Age of Sexual Initiation of Students from Polish Universities
por: Stokłosa, Maciej, et al.
Publicado: (2023)

Analysis of Factors Influencing Polish Students’ Opinions on Euthanasia
por: Stokłosa, Iga, et al.
Publicado: (2022)

Can biomarkers be used to diagnose attention deficit hyperactivity disorder?
por: Chen, Hui, et al.
Publicado: (2023)

An Exploratory Study of Emotional Dysregulation Dimensions in Youth With Attention Deficit Hyperactivity Disorder and/or Bipolar Spectrum Disorders
por: Masi, Gabriele, et al.
Publicado: (2021)

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
por: Chamakalayil, Sunsha, et al.
Publicado: (2021)

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Diagnosing attention-deficit hyperactivity disorder (ADHD) using artificial intelligence: a clinical study in the UK
por: Chen, Tianhua, et al.
Publicado: (2023)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Blood-Bourne MicroRNA Biomarker Evaluation in Attention-Deficit/Hyperactivity Disorder of Han Chinese Individuals: An Exploratory Study
por: Wang, Liang-Jen, et al.
Publicado: (2018)

Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)

Attention Deficit Hyperactivity Disorder in the Light of the Epigenetic Paradigm
por: Schuch, Viviane, et al.
Publicado: (2015)

Epigenetics and Attention-Deficit/Hyperactivity Disorder: New Perspectives?
por: Mirkovic, Bojan, et al.
Publicado: (2020)

Gray Matter Network Associated With Attention in Children With Attention Deficit Hyperactivity Disorder
por: Wang, Xing-Ke, et al.
Publicado: (2022)

Low serum sphingolipids in children with attention deficit-hyperactivity disorder
por: Henríquez-Henríquez, Marcela P., et al.
Publicado: (2015)

Alterations of Growth Factors in Autism and Attention-Deficit/Hyperactivity Disorder
por: Galvez-Contreras, Alma Y., et al.
Publicado: (2017)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Attention Deficit Hyperactivity Disorder: Association With Obesity and Eating Disorders
por: Ravi, Prithvi, et al.
Publicado: (2020)

Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders
por: Therribout, Norman, et al.
Publicado: (2022)

Tackling emotional processing in adults with attention deficit hyperactivity disorder and attention deficit hyperactivity disorder + autism spectrum disorder using emotional and action verbal fluency tasks
por: Walter, Amélia, et al.
Publicado: (2023)

Diagnostic Criteria in Attention Deficit Hyperactivity Disorder – Changes in DSM 5
por: Steinau, Sarah
Publicado: (2013)

Micronutrients and Diets in the Treatment of Attention-Deficit/Hyperactivity Disorder: Chances and Pitfalls
por: Lange, Klaus W.
Publicado: (2020)

Excessive Daytime Sleepiness Measurements in Children With Attention Deficit Hyperactivity Disorder
por: Bioulac, Stéphanie, et al.
Publicado: (2020)

Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder
por: Carta, Alessandra, et al.
Publicado: (2022)

Neural Correlates of Reactive Aggression in Adult Attention-Deficit/Hyperactivity Disorder
por: Jakobi, Babette, et al.
Publicado: (2022)

Resting-State Brain Variability in Youth With Attention-Deficit/Hyperactivity Disorder
por: Hong, Soon-Beom, et al.
Publicado: (2022)

Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder
por: Haavik, Jan
Publicado: (2022)

Perspectives on heterogeneity-informed cognitive training for attention-deficit/hyperactivity disorder
por: Zhang, Da-Wei
Publicado: (2023)

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder
por: Mattingly, Greg W., et al.
Publicado: (2023)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

Editorial: Old and new psychoactive substances: Pharmacology and potential applications
por: Mayer, Felix P., et al.
Publicado: (2023)

Attentional Profiles and White Matter Correlates in Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Type
por: Rossi, Adriana Suzart Ungaretti, et al.
Publicado: (2015)

A 4-Year Follow-Up Study of Attention-Deficit Hyperactivity Symptoms, Comorbidities, and Psychostimulant Use in a Brazilian Sample of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Palma, Sonia M. M., et al.
Publicado: (2015)

The Impact of the COVID-19 Pandemic on Diagnosing and Treating Attention Deficit Hyperactivity Disorder: New Challenges on Initializing and Optimizing Pharmacological Treatment
por: Segenreich, Daniel
Publicado: (2022)

Deficits in Response Inhibition in Patients with Attention-Deficit/Hyperactivity Disorder: The Impaired Self-Protection System Hypothesis
por: Coutinho, Thales Vianna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tvaeqvg6qj24bqp3a0u61r9cim